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Objective: Myocardial preservation studies comparing blood and crystalloid cardio-
plegia techniques were almost exclusively performed on patients undergoing coro-
nary bypass, and they were unable to show a difference in hospital mortality. We
investigated possible factors, including cardioplegia techniques, influencing hospital
mortality in patients undergoing cardiac valve surgery.
Methods: We evaluated hospital mortality in 1098 consecutive patients undergoing
cardiac valve surgery by using a multivariate logistic regression with propensity
score balancing of the groups. In 25% of the patients, multiple valve or Bentall
procedures were performed, and in 46% of all patients, coronary bypass grafting
was associated with valve surgery. A first cohort of 504 consecutive patients were
operated on by using single-shot antegrade cold crystalloid cardioplegia, and a
second cohort of 594 patients were operated on by using continuous retrograde cold
blood cardioplegia.
Results: After correction for patient-related and operative risk factors, lower hospital
mortality was found in patients who received retrograde blood cardioplegia (P 
.020). The odds ratio of in-hospital death when using blood cardioplegia was 0.44
(95% confidence interval, 0.22-0.88). Further predictors of hospital mortality were
age, advanced New York Heart Association functional class, cardiopulmonary
bypass time, reoperation, active endocarditis, and renal failure.
Conclusions: This study shows that continuous retrograde blood cardioplegia is
associated with lower hospital mortality in heart valve operations.
Most clinical studies on cardioplegia techniques have been donein patients undergoing coronary artery bypass grafting. Nev-ertheless, the advent of off-pump coronary artery bypasssurgery has reduced the necessity for it. On the contrary, fewstudies have been performed in patients undergoing valvesurgery in which cardioplegia is still fundamental. There is a
wide range of cardioplegia practices with significant intersurgeon and international
differences. Major controversies involve the temperature of cardioplegic solutions,
intermittence of delivery, and direction of flow. Properly designed randomized
clinical trials would be the ideal method for testing the outcome of different methods
of myocardial protection, but in cardiac surgery most improvements occurred
because of progressive changes in current practice. In the early 1990s, the most
common technique used in Europe was cold antegrade crystalloid cardioplegia. In
the United Kingdom, for example, in 1992, 58% of the surgeons used crystalloid
cardioplegia, 77% used antegrade cardioplegia, and 98% used cold cardioplegia.1
Because experimental studies showed that blood cardioplegia was advantageous
over crystalloid cardioplegia,2 blood cardioplegia gained interest. Obviously, excel-
lent protection can be obtained with the use of cold,3 warm,4,5 and tepid6,7 cardio-
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plegia. Furthermore, the rate of administration of cardiople-
gia (continuous or intermittent) seemed to matter more than
the means of administration (antegrade or retrograde).
In our institution, before November 7, 1994, we used
antegrade, single-shot cold crystalloid cardioplegia for all
isolated valves or valves combined with coronary bypass
operations. At this date, we switched to continuous cold
retrograde blood cardioplegia. Because all the patients were
operated on at one institution by one surgeon (W.F.) and
because the patient population was not supposed to have
changed dramatically over time, we decided to analyze, in a
retrospective way, early outcome in more than 1000 cardiac
valve operations. The objective of the study was to ascertain
whether the use of continuous retrograde blood cardioplegia
improved our results in terms of hospital mortality.
Methods
Patient Population
The study consists of 1098 consecutive adult patients operated on
by one surgeon (W.F.) at the KULeuven between November 4,
1991, and September 18, 1997. Nine hundred thirty-eight under-
went primary operations, and 160 underwent reoperations. All
patients undergoing valve surgery solely or combined with coro-
nary bypass grafting were included. The type of valve surgery and
its distribution between the groups is listed in Table 1. Excluded
were interventions with deep hypothermia and circulatory arrest,
cardiac transplantations, and non–valve-related operations.
Twenty percent of the valve procedures were reconstructions.
From November 4, 1991, until November 6, 1994, all patients
(n  504) were operated on with antegrade cold hyperkalemic
crystalloid cardioplegia8 combined with topical cooling of the
heart. From November 7, 1994, until September 18, 1997, all
patients (n  594) were operated on with retrograde cold blood
cardioplegia. The distribution of the type of interventions did not
significantly differ between the patient populations (ie, the crys-
talloid or blood cardioplegia groups (P .05). However, there was
a tendency to operate on more double-, triple-, and complex valve
cases in the most recent series. Also, patient characteristics dif-
fered between the groups: New York Heart Association (NYHA)
function class, body mass index (BMI), incidence of pulmonary
hypertension, and arterial hypertension were higher in the blood
cardioplegia group, and incidence of angina was lower (P  .05).
Cardioprotective Methods
As mentioned above, single-shot crystalloid cardioplegia was used
before November 6, 1994, in 504 consecutive patients. This hy-
perkalemic cardioplegic9 solution was delivered only by means of
antegrade infusion in the aortic root until septal temperature
reached 8°C. A minimum of 800 mL was used. Cooling of the
heart was maintained by means of topical application of slush ice.
The crystalloid cardioplegia was basically an oxygenized hy-
perkalemic solution. General cooling was applied to a rectal tem-
perature of 28°C. No multidose methods were used. In cases of
significant aortic regurgitation, direct coronary perfusion was used.
After November 6, 1994, retrograde blood cardioplegia was
used in 594 consecutive patients. A mixture of 3 volumes of blood
and one volume of crystalloid cardioplegia9 was infused at a
temperature of 10°C through the coronary sinus at a rate of 300
mL/min until the septal temperature reached 15°C and cardiople-
gic arrest was obtained. Then the infusion rate was diminished to
a minimum dose, allowing continuous cardiac arrest. General
cooling was applied to 28°C.
Statistical Methods
2 Tests and Student unpaired t tests were used to evaluate differ-
ences between the blood and crystalloid cardioplegia groups in
terms of patient characteristics, operative data, and mortality. 2
Tests and Student unpaired t tests were used to evaluate differ-
ences between the dead and surviving patients in terms of patient
characteristics and operative data. The variables included were
age, BMI, sex, left ventricular function, aortic crossclamp time,
cardiopulmonary bypass (CPB) time, smoking, diabetes, renal
failure, arterial hypertension, pulmonary hypertension, transient
ischemic attack, cardiovascular accident, chronic obstructive lung
disease, NYHA class, reoperation, myocardial infarction, angina,
cardiogenic shock, heart rhythm, aneurysm of ascending aorta,
type of operation (valve, valve plus coronary artery bypass graft-
ing, or ascending aorta replacement), aortic valve replacement,
mitral valve replacement, tricuspid valve replacement, active in-
fectious endocarditis, associated procedures, emergency status,
number of coronary vessels diseased, left main stem lesion, type of
cardioplegia, and mortality.
A logistic regression was used to establish the relationship
between hospital mortality and the covariates. Because this is not
a randomized study, an additional multivariate logistic regression
approach was used in which a propensity score model was used to
TABLE 1. Type of intervention
Crystalloid Blood
TotalCABG CABG CABG CABG
Single valve
Aortic 120 138 130 140 528
Mitral 67 69 76 74 286
Tricuspid 6 2 1 0 9
Double valve 55 26 79 42 202
Triple valve 6 5 25 4 40
Bentall  other complex 8 2 22 1 33
Total 262 242 333 261 1098
CABG, Coronary artery bypass grafting.
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correct for imbalances in preoperative variables between the
groups.10 Extensive preparative modeling with propensity score
models with continuous propensity scores or divided into 5 quin-
tiles, with models based on of all or only the most significant
differences between the 2 treatment groups, was performed and
checked for being multicolinear. After this preparative modeling, a
propensity score model was built on the basis of the preoperative
variables that differed between the treatment groups at a P value of
less than .1 (BMI, sex, CPB, arterial hypertension, pulmonary
hypertension, NYHA class, angina, and mitral valve replacement).
In the propensity score model we included the 8 main effects and
all 2-factor interactions and the squares of each effect, which
amounted to 36 variables altogether. We divided the predictive
values from this model, the propensity scores, into 5 quintiles. The
final model to predict mortality is based on these quintiles together
with a stepwise selection of all significantly different variables
between the 2 mortality groups (age, BMI, left ventricular func-
tion, CPB, aortic crossclamp, renal failure, active endocarditis,
NYHA class, reoperations, cardiogenic shock, heart rhythm, aortic
aneurysm, type of operation, tricuspid valve replacement, ascend-
ing aorta replacement, combined carotid artery surgery, emer-
gency, number of coronary vessels diseased, left main stem lesion,
and type of cardioplegia management). All statistical analyses
were performed with SAS software.
Results
Operative Characteristics
Mean  SD aortic crossclamp time was not different be-
tween the treatment groups: 76.7  25.7 minutes in the
crystalloid cardioplegia group and 76.0  30.5 minutes in
the blood cardioplegia group (P .66). CPB time, however,
was significantly shorter in the blood cardioplegia group
(110.0  43.6 minutes) than in the crystalloid cardioplegia
group (125.5  44.1 minutes, P  .0001).
Prediction of Hospital Mortality
Univariate analysis. The relationship between hospital
mortality and the following categoric variables was univa-
riately analyzed: blood cardioplegia, age, sex, BMI, diabe-
tes, type of operation, preoperative NYHA function class,
left ventricular function score, renal insufficiency, pulmo-
nary hypertension, arterial hypertension, active endocardi-
tis, reoperation, angina, cardiogenic shock, aneurysm of the
ascending aorta, carotid artery surgery, emergency condi-
tions, number of coronary vessels diseased, left main stem
lesion, crossclamp time, CPB time, and cardiac rhythm. The
nonuse of blood cardioplegia resulted in a hospital mortality
of 8.5% versus 5.2% when blood cardioplegia was used
(P  .03). Furthermore, patients who died were signifi-
cantly older, had worse ventricular function, had longer
aortic crossclamp and CPB times, had more renal failure,
had more active endocarditis, had a higher NYHA class, had
received more often a previous cardiovascular intervention,
were more often in cardiogenic shock (P  .001), had a
pacemaker rhythm preoperatively (P  .01), more fre-
quently had aorta ascendens replacements (P .02), needed
more tricuspid valve replacement or carotid artery surgery
(P  .01), had a significantly higher number of diseased
coronary vessels (P  .001), were more likely to have a left
main stem stenosis (P  .02), and underwent additional
coronary artery bypass grafting surgery (P  .02).
Multivariate analysis. Stepwise selection of all signifi-
cantly different variables between the 2 mortality groups
yielded the following effects: CPB time (2  58.55, P 
.001), NYHA class (2  14.38, P  .001), age (2 
15.13, P .001), active endocarditis (2 9.43, P .002),
reoperation (2 7.15, P .007), blood cardioplegia (2
6.03, P .014), and renal failure (2 5.51, P .019). As
a result, our final model to estimate mortality will contain
these variables: CPB time, age, NYHA class, active endo-
carditis, reoperation, renal failure, and blood cardioplegia.
We then add the propensity score quintiles in the model,
where we try to correct for the nonrandomization.
The addition of the quintiles does not change the model
very much: the R2 augments from 0.2769 to 0.2965, the
parameter estimates are almost the same in both models, the
Hosmer and Lemeshow test indicates that the model has a
good fit (0.1436), and there is no multicollinearity in the
model. For the analysis of maximum likelihood estimates,
see the Appendix.
First, we should remark that the stepwise selection mech-
anism chose blood cardioplegia as a significant predictor of
mortality out of 20 possible variables. This variable has a P
value of .020 and is thus highly significant in predicting
mortality. Although we corrected for the effects of age, CPB
time, NYHA class, reoperations, renal failure, and active
endocarditis on mortality and, moreover, we balanced the
treatment groups for a whole range of variables with the
propensity score, we still find a significant treatment effect.
The odds of mortality when being operated on with
blood cardioplegia are 44% of the odds of mortality when
operated on with crystalloid cardioplegia. Therefore pa-
tients being operated on with crystalloid cardioplegia have a
more than double chance of dying after valve surgery than
if blood cardioplegia is used. The 95% confidence interval
for this odds ratio is 0.218 to 0.876.
Discussion
These results show that hospital mortality in valve opera-
tions and combined valve and coronary bypass operations
can be influenced by the choice of the myocardial protection
technique. In a comparable study in mainly coronary bypass
operations, Loop and colleagues9 could not show this effect,
although a significant reduction in morbidity was demon-
strated with the use of blood cardioplegia. Our study shows
that in absolute figures hospital mortality is reduced from
8.5% to 5.2% in the cohort of patients operated on with
blood cardioplegia instead of crystalloid cardioplegia. The
multivariate analysis revealed the use of retrograde blood
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cardioplegia as an independent predictor of hospital mortal-
ity, with an odds ratio of 0.44 and a 95% confidence interval
of 0.218 to 0.876. Therefore in the worst case patients being
operated on with blood cardioplegia have a reduced chance
of mortality of greater than 10% and, in the best case, a
reduction of almost 80%. This means that independent from
any other factor, blood cardioplegia reduces hospital mor-
tality by approximately 50%. In addition to this, other
independent factors increasing hospital mortality are age,
NYHA function class, CPB time, active endocarditis, reop-
erations, and renal failure. Most of these factors were al-
ready identified earlier.11
Another interesting finding is that in the univariate anal-
ysis aortic crossclamp time, duration of CPB, and the com-
plexity of the operation are significantly related to hospital
mortality. An isolated (single or multiple) valve procedure
has an overall hospital mortality of 4.3%, and a combined
valve and coronary bypass operation has a mortality of 7.8%
when the main stem is normal and a mortality of 13.6%
when the left main stem is involved. In the multivariate
analysis, however, aortic crossclamp time and type of op-
eration are no longer significant predictors of hospital mor-
tality.
It must be noted that the addition of propensity scores did
not change the conclusions of the present study. The mag-
nitude and significance of the effects of the influencing
factors barely changed. No additional predictors were
found, nor were predictors deleted from the model with or
without propensity score quintiles included.
In addition to the choice of crystalloid or blood cardio-
plegia, other factors can differ between current cardioplegia
techniques. These involve temperature, intermittence of de-
livery, and direction of flow. Two different routes of appli-
cation are available, antegrade and retrograde, as well as the
combination of both. Although retrograde cardioplegia is
increasing in popularity, concerns have been raised about
the adequacy of perfusion of the right ventricle. It was
shown by Menasche´ and coworkers12 and our group13 that
right ventricular function is adequately preserved after cor-
onary sinus cardioplegia. Furthermore, we could show that
in the presence of coronary artery obstruction, retrograde
delivery was superior to antegrade delivery.14 However,
Arom and associates15 evaluated the 2 different routes of
cardioplegia in more than 7000 patients and found that
retrograde cardioplegia alone provides myocardial protec-
tion and safety that is just as good as that provided by an
antegrade-retrograde approach in either low-risk or high-
risk patients.
Controversy still exists as to whether blood cardioplegia
should be warm or cold. In a large randomized trial in 1700
coronary bypass operations, warm versus cold antegrade
blood cardioplegia was compared, and a favorable cardiac
outcome with warm heart surgery was demonstrated.4 In
another randomized trial involving 1001 patients, continu-
ous warm blood cardioplegia was shown to have similar
mortality and cardiac outcome as antegrade cold crystalloid
cardioplegia, but strokes and total neurologic events were
greater in the warm cardioplegia group.16 In another clinical
study it was proposed that optimal cardioplegia might ac-
tually be tepid (29°C).7
Cardioplegia was initially developed not only to protect
the myocardium but also to create a quiet and bloodless
surgical field. Continuous blood cardioplegia has a serious
disadvantage because of limited visibility. This resulted in
widespread use of the intermittent instead of continuous
application of blood cardioplegia. However, it was shown17
that continuous cold blood cardioplegia results in fewer
cardiac events, better left ventricular performance, and a
marked improvement of right ventricular function in com-
parison with similar solutions of blood cardioplegia admin-
istered intermittently, independent of their means of deliv-
ery. In practice, uninterrupted delivery of blood
cardioplegia is hardly possible, and therefore most proce-
dures are done with intermittent cardioplegia delivery. This
is also the case in our operations, although cardioplegia was
never interrupted for longer than 10 minutes. In warm blood
cardioplegia it is important that any single period of isch-
emia (ie, time off cardioplegia) is limited to less than 14
minutes because otherwise, adverse clinical events increase
significantly.18
Basically, in coronary bypass surgery a significant lower
mortality with the use of cold9 or warm3,5 blood cardiople-
gia than with the use of antegrade cold crystalloid cardio-
plegia could not be shown, in either historical9 or random-
ized clinical trials.3,5 In contrast, our study shows a clear
influence of the type of cardioprotection on hospital mor-
tality in valve procedures and combined valve and coronary
bypass procedures. This was indicated by the findings of
Chitwood and colleagues,19 who described, in an uncon-
trolled study of 194 patients undergoing complex cardiac
procedures, a 30-day mortality rate of 3.1% with combined
antegrade and retrograde cold blood cardioplegia.
In conclusion, we found that patients undergoing valvu-
lar cardiac surgery who received continuous retrograde
blood cardioplegia had lower perioperative mortality than
patients receiving single-dose antegrade crystalloid cardio-
plegia. However, the association between the use of blood
cardioplegia and better results does not imply a causal
relationship and certainly does not exclude the influence on
hospital mortality of recent overall improvements in cardiac
surgery, which cannot be traced by means of sophisticated
statistical techniques.
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Appendix. Analysis of maximum likelihood estimate
Parameter
Model with propensity score quintiles Model without propensity score quintiles
Estimate SE 2 P > 2 Estimate SE 2 P > 2
Intercept 11.8038 1.9394 37.0435 .001 12.1844 1.8871 41.6879 .001
Age 0.1071 0.0251 18.1871 .001 0.1060 0.0246 18.5181 .001
CPB 0.0148 0.0033 20.1666 .001 0.0148 0.0032 22.0293 .001
NYHA class  1 0.8906 0.3881 5.2646 .022 1.0934 0.3697 8.7449 .003
Reoperation  1 0.8693 0.3301 6.9349 .008 0.8343 0.3268 6.5187 .011
Blood cardioplegia 0.8278 0.3546 5.4501 .020 0.8508 0.3308 6.6154 .010
Quintile 5 0.2618 0.6167 0.1802 .671
Quintile 4 0.5072 0.4991 1.0326 .310
Quintile 3 0.7925 0.4758 2.7745 .096
Quintile 2 0.8532 0.4676 3.3289 .068
Renal failure 1.1400 0.5852 3.7947 .051 1.2532 0.5649 4.9217 .0265
Active endocarditis 2.4752 0.8377 8.7317 .003 2.2629 0.8434 7.1990 .007
For explanation of the used statistical methods and variables, please see “Statistical Methods” section and “Prediction of Hospital Mortality: Multivariate
Analysis” section. CABG, Coronary artery bypass grafting.
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